References

mes

Экстремальная биомедицина

Extreme Medicine

3033-89643033-8972

Centre for Strategic Planning of the Federal Medical and Biological Agency

10.47183/mes.2023.021

mes-136

Research Article

ОБЗОР

REVIEW

Особенности курации спортсменов при затяжных вариантах течения COVID-19

Particularities of curation of athletes with protracted course of COVID-19

Балыкова

Л. А.

Balykova LA

L. A.

Саранск

Saransk

Жолинский

А. В.

Zholinsky

A. V.

Москва

Moscow

Тарасова

М. С.

Tarasova

M. S.

Мария Сергеевна Тарасоваул. Б. Дорогомиловская, д. 5, г. Москва, 121059

Maria S. TarasovaB. Dorogomilovskaya, 5, Moscow, 121059

arasovams@sportfmba.ru

Ивянский

С. А.

Ivyanskiy

S. A.

Саранск

Saransk

Базанович

С. А.

Bazanovich

S. A.

Москва

Moscow

Ширманкина

М. В.

Shirmankina

M. V.

Саранск

Saransk

Беспалов

Р. А.

Bespalov

R. A.

Саранск

Saransk

Ефимов

П. В.

Efimov

P. V.

Москва

Moscow

Гришина

Ж. В.

Grishina

Zh. V.

Москва

Moscow

Парастаев

С. А.

Parastaev

S. A.

Москва

Moscow

Мордовский государственный университет имени Н. П. ОгарёваРоссияOgaryov National Research Mordovian State UniversityRussian Federation

Федеральный научно-клинический центр спортивной медицины и реабилитации Федерального медико-биологического агентстваРоссияFederal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical Biological AgencyRussian Federation

Российский национальный исследовательский медицинский университет имени Н. И. Пирогова Минздрава РоссииРоссияFederal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical Biological AgencyRussian Federation

Федеральный научно-клинический центр спортивной медицины и реабилитации Федерального медико-биологического агентства; Российский национальный исследовательский медицинский университет имени Н. И. Пирогова Минздрава РоссииРоссияFederal Research and Clinical Center of Sports Medicine and Rehabilitation of Federal Medical Biological Agency; Pirogov Russian National Research Medical UniversityRussian Federation

2023

26102024

2524150

2024

Балыкова Л.А., Жолинский А.В., Тарасова М.С., Ивянский С.А., Базанович С.А., Ширманкина М.В., Беспалов Р.А., Ефимов П.В., Гришина Ж.В., Парастаев С.А.

Balykova LA L.A., Zholinsky A.V., Tarasova M.S., Ivyanskiy S.A., Bazanovich S.A., Shirmankina M.V., Bespalov R.A., Efimov P.V., Grishina Z.V., Parastaev S.A.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.extrememedicine.ru/jour/article/view/136

Представлен обзор публикаций, посвященных отсроченным клиническим и функциональным проявлениям коронавирусной инфекции SARS-CoV2 в контингенте спортсменов национального и международного уровней; дана характеристика распространенности полиорганных поражений при затяжном течении коронавирусной инфекции среди спортсменов, а также лиц, не занимающихся спортом. Описаны результаты ретроспективного анализа данных клинико-инструментального и лабораторного тестирования спортсменов сборной команды России, перенесших COVID-19. Выделены наиболее информативные показатели, отражающие состояние спортсменов с пролонгированным течением коронавирусной инфекции; определены подходы к безопасному возобновлению спортивной деятельности, сформирован перечень наиболее значимых критериев допуска к тренировочному и соревновательному процессу. Определены параметры, подлежащие включению в прогностическую модель (бинарную логистическую регрессию) динамики резидуальных полиорганных нарушений у спортсменов, в том числе несовершеннолетних, перенесших коронавирусную инфекцию или вирусную пневмонию иной этиологии

This paper reviews publications covering the delayed clinical and functional manifestations of SARS-CoV2 among athletes competing at national and international levels; we describe the prevalence of multiorgan failure associated with protracted COVID as registered in sportsmen and people not going in for sports. The review reports the results of a retrospective analysis of data yielded from clinical, instrumental and laboratory tests undertaken by the Russian national team athletes that had COVID-19. We highlight the most informative indicators that reflect the condition of sportsmen with protracted coronavirus infection course, define the approaches making resumption of active training safe and compile the list of the most significant criteria supporting admission to such training and competitions. Lastly, the paper presents the parameters subject to inclusion in the prognostic model (binary logistic regression) describing the dynamics of residual multiorgan failure in athletes, including minors, who have had COVID-19 or viral pneumonia of a different etiology.

спорт высших достиженийэлитные спортсменыкоронавирусная инфекция SARS-CoV2постковидный синдромкардиоваскулярная системамиокардит в спортемультисистемный воспалительный синдромбинарная логистическая регрессия

elite sportselite athletesSARS-CoV2 coronavirus infectionpost-Covid syndromecardiovascular systemmyocarditis in sportsmultisystem inflammatory syndromebinary logistic regression

статья подготовлена в рамках прикладной научно-исследовательской работы «Изучение влияния новой коронавирусной инфекции COVID-19 на здоровье и функциональное состояние высококвалифицированных спортсменов и разработка методических рекомендаций по обследованию спортсменов, включая несовершеннолетних, по допуску спортсменов к тренировкам и соревнованиям после перенесенного заболевания COVID-19, по восстановлению их здоровья и функционального состояния» (шифр «COVID-22»), выполняемой ФГБУ ФНКЦСМ ФМБА России по государственному контракту №107.003.22.14 от 25 июля 2022 г.

References1

Zholinsky AV, Kruglova IV, Feshchenko VS, Risukhina YV, Fomin AV, Galaktionova NM, et al. Federal medical biological agency of Russia's efforts to support Russian athletes during COVID-19 outbreak. Sport Sci Health. 2022; 18 (3): 831–7. DOI: 10.1007/ s11332-021-00861-5. Epub 2021 Nov 6. PMID: 34777596; PMCID: PMC8571973.

World Health Organization. Available from: https://www.who.int/ europe/emergencies/situations/covid-19

Амиров Н. Б., Давлетшина Э. И., Васильева А. Г., Фатыхов Р. Г. Постковидный синдром: мультисистемные «дефициты». Вестник современной клинической медицины. 2021; 14 (6).

Amirov NB, Davletshina EhI, Vasileva AG, Fatyxov RG. Postkovidnyj sindrom: mul'tisistemnye «deficity». Vestnik sovremennoj klinicheskoj mediciny. 2021; 14 (6). Russian.

Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO clinical case definition working group on post-COVID-19 condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022; 22 (4): e102–e107. DOI: 10.1016/S1473-3099(21)00703-9. Epub 2021 Dec 21. PMID: 34951953; PMCID: PMC8691845.

Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022; 28 (5): 657–66. DOI: 10.1016/j.cmi.2022.01.014. Epub 2022 Feb 3. PMID: 35124265; PMCID: PMC8812092.

Perrone MA, Volterrani M, Manzi V, Barchiesi F, Iellamo F. Heart rate variability modifications in response to different types of exercise training in athletes. J Sports Med Phys Fitness. 2021; 61 (10): 1411–5. DOI: 10.23736/S0022-4707.21.12480-6. Epub 2021 Jun 17 PMID: 34137572.

Powell AW, Urbina EM, Orr WB, Hansen JE, Baskar S. EKG abnormalities in a youth athlete following COVID-19: it's not always myocarditis! Pediatr Cardiol. 2022; 43 (8): 1922–5. DOI: 10.1007/s00246-022-02935-8. Epub 2022 May 27. PMID: 35622085; PMCID: PMC9136195.

Tanacli R, Doeblin P, Götze C, Zieschang V, Faragli A, Stehning C, et al. COVID-19 vs. Classical myocarditis associated myocardial injury evaluated by cardiac magnetic resonance and endomyocardial biopsy. Front Cardiovasc Med. 2021; 8: 737257. DOI: 10.3389/ fcvm.2021.737257. PMID: 35004872; PMCID: PMC8739473

Wulf HS, Abbafati C, Aerts JG, et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 2022.

Oikonomou E, Lampsas S, Theofilis P, Souvaliotis N, Papamikroulis GA, Katsarou O, et al. Impaired left ventricular deformation and ventricular-arterial coupling in post-COVID-19: association with autonomic dysregulation. Heart Vessels. 2023; 38 (3): 381–93. DOI: 10.1007/s00380-022-02180-2. Epub 2022 Sep 28.

Antonelli M, et al. Risk factors and disease profile of post- vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. The Lancet Infectious Diseases. 2022; 22: 43–55

Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. 2021. DOI: 10.1101/2021.10.26.21265508. Available from: http://medrxiv. org/lookup/doi/10.1101/2021.10.26.21265508.

Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. 2021. DOI 10.1101/2021.10.26.21265508. Available from: http://medrxiv. org/lookup/doi/10.1101/2021.10.26.21265508.

Tran V-T, Perrodeau E, Saldanha J, Pane I, Ravaud P. Efficacy of COVID-19 vaccination on the symptoms of patients with long COVID: a target trial emulation using data from the ComPaRe e-cohort in France. 2022. DOI: 10.21203/rs.3.rs-1350429/ v1. Available from: https://www.researchsquare.com/article/rs- 1350429/v1.

Ashton RE, Philips BE, Faghy M. The acute and chronic implications of the COVID-19 virus on the cardiovascular system in adults: A systematic review. Prog Cardiovasc Dis. 2023; 76: 31–37. DOI: 10.1016/j.pcad.2023.01.003.

Sandoval Y, Januzzi JL, Jr, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am CollCardiol. 2020; 76: 1244–58.

Carfi A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324: 603–5.

Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021; 4.

Giustino G, Croft LB, Stefanini GG, et al. Characterization of myocardial injury in patients with COVID-19. J Am CollCardiol. 2020; 76: 2043–55.

Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020; 5: 1265–73.

O'Connor FG. COVID-19: Return to sport or strenuous activity following infection. UpToDate. Literature review current through: May 2022. This topic last updated: Mar 28, 2022.

Ali-Ahmed F, Dalgaard F, Al-Khatib SM. Sudden cardiac death in patients with myocarditis: evaluation, risk stratification, and management. Am Heart J. 2020; 220: 29–40.

Phelan D, Kim JH, Elliott MD, et al. Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement. JACC Cardiovasc Imaging. 2020; 13 (12): 2635–52. DOI: 10.1016/j.jcmg.2020.10.005.

Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019; 40 (1): 19–33.

Wilson MG, Hull JH, Rogers J, et al. Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. Br J Sports Med. 2020; 54 (19): 1157–61. DOI: 10.1136/bjsports-2020-102710.

Dove J, Gage A, Kriz P, Tabaddor RR, Owens BD. COVID-19 and review of current recommendations for return to athletic play. R I Med J. 2020; 103 (7): 15–20. Published 2020 Sep 1.

Moulson N, Petek BJ, Drezner JA, et al. SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes. Circulation. 2021; 144 (4): 256–66. DOI: 10.1161/CIRCULATIONAHA.121.054824.

Kim JY, Han K, Suh YJ. Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2021; 23 (1): 100. DOI: 10.1186/s12968-021- 00792-7.

Van Hattum JC, Spies JL, Verwijs SM, et al. Cardiac abnormalities in athletes after SARS-CoV-2 infection: a systematic review. BMJ Open Sport Exerc Med. 2021; 7 (4): e001164. Published 2021 Oct 12. DOI: 10.1136/bmjsem-2021-001164.

Kelle S, Bucciarelli-Ducci C, Judd RM, et al. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection. J Cardiovasc Magn Reson. 2020; 22: 61.

Małek LA, Bucciarelli-Ducci C. Myocardial fibrosis in athletes- Current perspective. Clin Cardiol. 2020; 43 (8): 882–8.

Ahmad SA, Khalid N, Shlofmitz E, Chhabra L. Myocardial fibrosis and arrhythmogenesis in elite athletes. Clin Cardiol. 2019; 42 (9): 788.

Zhang CD, Xu SL, Wang XY, Tao LY, Zhao W, Gao W. Prevalence of myocardial fibrosis in intensive endurance training athletes: a systematic review and meta-analysis. Front Cardiovasc Med. 2020; 7: 585692.

Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021; 6 (1): 116–8. DOI: 10.1001/jamacardio.2020.4916.

Gluckman TJ, Bhave NM, Allen LA, et al. 2022 ACC Expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022; 79 (17): 1717–56.

Daniels CJ, Rajpal S, Greenshields JT, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021; 6: 1078–87.

Brito D, Meester S, Yanamala N, et al. High prevalenceof pericardial involvement in college studentathletes recovering from COVID-19. J Am Coll Cardiol Img. 2021; 14: 541–55.

Clark DE, Parikh A, Dendy JM, et al. COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR). Circulation. 2021; 143: 609–12.

Hwang CE, Kussman A, Christle JW, et al. Findingsfrom cardiovascular evaluation of National Collegiate Athletic Association Division I collegiate studentathletesafter asymptomatic or mildly symptomatic SARS-CoV-2 infection. Clin J Sport Med. Published online June 24, 2021.

Starekova J, Bluemke DA, Bradham WS, et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021; 6: 945–50.

Martinez MW, Tucker AM, Bloom OJ, et al. Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol. 2021; 6: 745–52.

Valverde I, Singh Y, Sanchez-de-Toledo J, et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation. 2021; 143: 21–32.

Sirico D, Basso A, Reffo E, et al. Early echocardiographic and cardiac MRI findings in multisystem inflammatory syndrome in children. J Clin Med. 2021; 10 (15): 3360.

Palabiyik F, Akcay N, Sevketoglu E, et al. Imaging of multisystem inflammatory disein children (MIS-C) associated With COVID-19. Acad Radiol. 2021; 28: 1200–8.

Cavigli L, et al. A prospective study on the consequences of SARS- CoV-2 infection on the heart of young adult competitive athletes: implications for a safe return-to-play. International journal of cardiology. 2021; 336: 130–6. DOI: 10.1016/j.ijcard.2021.05.042.

Modica G, Bianco M, Sollazzo F, et al. Myocarditis in athletes recovering from COVID-19: a systematic review and meta- analysis. Int J Environ Res Public Health. 2022; 19 (7): 4279.

Ibarrola M, Dávolos I. Myocarditis in athletes after COVID-19 infection: the heart is not the only place to screen. Sports Med Health Sci. 2020; 2: 172–3.

Chevalier L, Cochet H, Mahida S, et al. ASCCOVID investigators. Resuming training in high-level athletes after mild COVID-19 infection: a multicenter prospective study (ASCCOVID-19). Sports Med Open. 2022; 8 (1): 83. DOI: 10.1186/s40798-022-00469-0.

Gamal DM, Ibrahim RA, Samaan SF. Post COVID-19 syndrome in a prospective cohort study of Egyptian patients. Egypt Rheumatol Rehabil. 2022; 49 (1): 12. Available from: https://doi.org/10.1186/ s43166-021-00104-y.

Nabavi N. Long COVID: how to define it and how to manage it. BMJ. 2020; 370: m3489. Published 2020 Sep 7. DOI: 10.1136/ bmj.m3489.

Giusto E, Asplund CA. Persistent COVID and a return to sport. Curr Sports Med Rep. 2022; 21 (3): 100–4.

Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021; 69 (2): 205–11. DOI: 10.1007/s12026-021-09185-5.

Phelan D, Kim JH, Chung EH. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol. 2020; 5: 1085–6.

Baggish A, Drezner JA, Kim J, Martinez M, Prutkin JM. The resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes. Br J SportsMed. 2020;54: 1130–1.

Baggish A, Drezner JA, Kim J, Martinez M, Prutkin JM. The resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes. Br J SportsMed. 2020; 54: 1130–1.

Kim JH, Levine BD, Phelan D, et al. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021; 6: 219–27.

Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020; 383: 334–46.

Maron BJ, Udelson JE, Bonow RO. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015; 66: 2362–71.

The authors declare that there are no conflicts of interest present.